Viewing StudyNCT00256828



Ignite Creation Date: 2024-05-05 @ 12:08 PM
Last Modification Date: 2024-10-26 @ 9:21 AM
Study NCT ID: NCT00256828
Status: COMPLETED
Last Update Posted: 2007-10-16
First Post: 2005-11-21

Brief Title: Once a Day QD - Twice a Day BID Clinical Trial Didanosine Lamivudine and Efavirenz Versus Zidovudine Lamivudine and Efavirenz in the Starting Treatment of HIV
Sponsor: Clinical Trial Agency of HIV Study Group
Organization: Clinical Trial Agency of HIV Study Group

Conditions & Keywords Data

Conditions:
Name
HIV Infections
Keywords:
Name View
Treatment Naive View
HIV infection View
Highly active antiretroviral therapy View